Teenage Smoking Rate Decreased, but E-cigarette Use Increased

Aug.21.2023
Teenage Smoking Rate Decreased, but E-cigarette Use Increased
Teenage smoking rates decline during COVID-19, but e-cigarette use increases, alcohol consumption remains stable, and mental health deteriorates.

According to a recent survey conducted by the Korea Centers for Disease Control and Prevention (KCDC), the overall smoking rate among teenagers has decreased in the past two years since the outbreak of COVID-19. The survey, titled the "17th Youth Health Behavior Survey," collected data from approximately 60,000 students from middle school first grade to high school third grade between August and November last year.

 

The statistics revealed that the smoking and drinking habits of teenagers remained stable in 2020, after experiencing a significant drop compared to 2019, the year before the COVID-19 pandemic. The percentage of teenagers who reported smoking cigarettes for more than one day in the past month was 4.5%, a similar level to the previous year (4.4%), and lower than the pre-pandemic rate of 6.7% in 2019.

 

The KCDC attributed this trend to the increase in remote learning and the decrease in peer gatherings during the pandemic period. However, the use of e-cigarettes increased, with the usage rates of liquid-type e-cigarettes rising from 1.9% to 2.9% in a year, and cartridge-type e-cigarettes increasing from 1.1% to 1.4%.

 

In terms of alcohol consumption, the percentage of teenagers who reported drinking at least one glass in the past 30 days remained the same at 10.7%. The "current drinking rate" also showed no significant increase since it dropped from 15.0% in 2019 to 10.7% in 2020.

 

While the average alcohol consumption rate in the past month decreased slightly from 5.2% in 2020 to 4.9% in 2021, indicating a decline in risky drinking behaviors, the accessibility to purchase tobacco and alcohol increased. The percentage of teenagers who reported that they could easily buy cigarettes or alcohol from convenience stores or shops increased significantly compared to the previous year, with the accessibility rate for cigarette purchases rising from 67.0% to 74.8% and for alcohol purchases from 63.5% to 71.3%.

 

While the percentage of teenagers engaging in regular physical activities increased slightly to 14.6% who participated in at least 60 minutes of physical activity for five or more days a week, the dietary habits did not improve. The percentage of teenagers skipping breakfast for five or more days a week continued to rise, reaching 38.0% in 2021, compared to 27.9% in 2015. Additionally, the percentage of teenagers consuming fruits decreased for the fifth consecutive year, recording 18.1% in 2021.

 

Mental health indicators also worsened in 2021 compared to the previous year. The prevalence of depression increased from 25.2% in 2020 to 26.8%, and the perceived stress rate rose from 34.2% to 38.8%. Females showed higher rates of depression (31.4%) and stress (45.6%) compared to males (22.4% and 32.3% respectively).

 

In conclusion, while the smoking rate among teenagers has decreased during the COVID-19 pandemic, the use of e-cigarettes has increased. Additionally, there has been no significant change in alcohol consumption, but the accessibility to purchase tobacco and alcohol has increased. Furthermore, despite a slight increase in regular physical activity, detrimental dietary habits and worsening mental health indicators are concerning issues among teenagers.


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
Multiple JTI-backed studies in the UK and Ireland indicate that illicit tobacco remains visible across consumer interactions and local markets. In the UK, JTI research found that 31% of respondents said they had been offered illicit tobacco products. In Ireland’s Ennis area, a JTI-commissioned empty pack survey found that 63% of sampled cigarette packs did not carry Irish duty-paid markings. The findings come from industry research rather than official government estimates of illicit tobacco market size, but highlight continued concerns among regulators, legitimate retailers and tobacco companies over illicit trade.
Aug.19
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
Ohio Supreme Court Weighs Whether State Consumer Law Can Restrict Flavored Vape Sales
Ohio Supreme Court Weighs Whether State Consumer Law Can Restrict Flavored Vape Sales
The Ohio Supreme Court is hearing a case involving flavored vape sales and whether state authorities can use consumer protection laws to take action against retailers selling unauthorized vape products. Ohio officials argue that selling unauthorized flavored vapes may constitute consumer deception, while retailers argue that tobacco product regulation falls under federal Food and Drug Administration (FDA) authority and that states cannot impose additional restrictions through consumer laws. The case could affect the scope of state-level vape regulation across the United States.
Aug.06
Nicotine Pouches Gain Ground in U.S. Convenience Stores as Vape Unit Sales Fall 14%
Nicotine Pouches Gain Ground in U.S. Convenience Stores as Vape Unit Sales Fall 14%
According to convenience retail publication CStore Decisions, U.S. convenience store tobacco categories are undergoing a structural shift. Based on Circana OmniMarket Total U.S. Convenience data for the 52 weeks ending June 14, 2026, cigarettes remained the largest category with $50.8 billion in sales, but unit sales declined 5.3%. Electronic smoking devices and vaping products also declined, while modern oral nicotine products continued to grow, with nicotine pouch sales rising 29% in dollars and 17% in units. Retailers said changing consumer preferences are reshaping tobacco product assortments at convenience stores.
Regulations
Aug.07
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives